New eye drops aim to heal corneal scars in early trial

NCT ID NCT06257355

Recruiting now Disease control Sponsor: Claris Biotherapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Apr 23, 2026 · Last updated May 01, 2026 · Updated 2 times

Summary

This early study tests an experimental eye drop (CSB-001) in 20 people with recent corneal scars (formed 7-30 days ago). Participants use the drops 3-4 times daily for up to 14 days. The main goals are to check safety and see if the drops reduce scar size and improve vision.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Francis Price Jr, MD
RECRUITING

Indianapolis, Indiana, 46260, United States

Contact
Legacy Devers Eye Institute
RECRUITING

Portland, Oregon, 97210, United States

Contact
Loma Linda University Eye Institute
RECRUITING

Loma Linda, California, 92354, United States

Contact
Midwest Cornea Associates, LLC
RECRUITING

Carmel, Indiana, 46290, United States

Contact
Minnesota Eye Consultants
RECRUITING

Minnetonka, Minnesota, 55305, United States

Contact
Stuart A. Terry, MD PA
RECRUITING

San Antonio, Texas, 78212, United States

Contact
Virginia Eye Consultants
RECRUITING

Norfolk, Virginia, 23502, United States

Contact

Conditions

Explore the condition pages connected to this study.

CORNEAL SCAR